Precision Optics Corp.
POCI Healthcare Medical Instruments & Supplies
Precision Optics Corp.’s revenue for fiscal 2026 (year ended June 2026) was $31.5 million, up 65.2% from fiscal 2025. In the quarter to June 2026, revenue grew 42.0%, EPS grew 117.4%, free cash flow fell 45.6% and total debt fell 31.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow POCI
Precision Optics Corp. (POCI) Altman Z-score
Precision Optics Corp.'s Altman Z-score for fiscal 2026 is 0.59, in the distress zone (below 1.81).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2026 | 0.59 | 1.69 |
| FY2025 | −1.10 | (0.76) |
| FY2024 | −0.34 | (0.88) |
| FY2023 | 0.54 | 1.37 |
| FY2022 | −0.83 | 3.32 |
| FY2021 | −4.15 | 1.90 |
| FY2020 | −6.05 | (0.51) |
| FY2019 | −5.54 | 16.57 |
| FY2018 | −22.11 | 9.97 |
| FY2017 | −32.08 | (5.26) |
How fiscal 2026’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.35 | — | 0.42 | |
| Retained earnings / total assets | (1.87) | — | −2.62 | |
| EBIT / total assets | (0.11) | — | −0.36 | |
| Market value of equity / total liabilities | 3.63 | — | 2.18 | |
| Sales / total assets | 0.98 | — | 0.98 | |
| Altman Z-score | Distress zone | 0.59 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −2.77 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| POCI Precision Optics Corp. | 0.6× |
| ZTEKF Zentek Ltd. compare | −2.1× |
| NEPH Nephros Inc. compare | −3.3× |
| HBIO Harvard Bioscience, Inc. compare | −4.0× |
| NYXH Nyxoah SA compare | −4.4× |
| STXS Stereotaxis Inc. compare | −12.4× |
| MBOT Microbot Medical Inc. compare | −19.4× |
| MLSS Milestone Scientific, Inc. compare | −22.1× |
| DXR Daxor Corporation compare | — |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets